Literature DB >> 18004018

Submicrobial doxycycline and rosacea.

Ronald D Wise1.   

Abstract

Rosacea is a disease of inflammation with no pathogenic bacteria involved. Successful treatment of rosacea is possible without using antimicrobial preparations. Oracea capsules provide the antiinflammatory benefits of doxycycline without contributing to the development of resistance to doxycycline.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18004018     DOI： 10.1007/s12019-007-8003-x

Source DB:  PubMed          Journal:  Compr Ther        ISSN： 0098-8243


  5 in total

Review 1.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

Review 2.  Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit.

Authors:  Aimee M Two; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

3.  Safety and efficacy of doxycycline in the treatment of rosacea.

Authors:  Sheila Valentín; Adisbeth Morales; Jorge L Sánchez; Abimael Rivera
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-08-12

Review 4.  Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments.

Authors:  Martin Steinhoff; Marc Vocanson; Johannes J Voegel; Feriel Hacini-Rachinel; Gregor Schäfer
Journal:  Adv Ther       Date:  2016-07-18       Impact factor: 3.845

Review 5.  Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition.

Authors:  Yu Ri Woo; Ji Hong Lim; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2016-09-15       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.